|
Device | PulseSelect™ Pulsed Field Ablation (PFA) system |
Generic Name | Percutaneous Cardiac Ablation Catheter for Treatment of Atrial Fibrillation with Irreversible Electroporation |
Applicant | Medtronic, Inc. 8200 Coral Sea Street NE Mounds View, MN 55112 |
PMA Number | P230017 |
Date Received | 05/05/2023 |
Decision Date | 12/13/2023 |
Product Code |
QZI |
Advisory Committee |
Cardiovascular |
Clinical Trials | NCT04198701
|
Expedited Review Granted? | No |
Combination Product | No |
Approval Order Statement Approval for the PulseSelect™ Pulsed Field Ablation (PFA) System. This device is indicated for cardiac electrophysiological mapping (stimulation and recording) and for treatment of drug refractory, recurrent, symptomatic paroxysmal atrial fibrillation or persistent atrial fibrillation (episode duration less than 1 year). |
Post-Approval Study | Show Report Schedule and Study Progress |
Supplements: |
S002 |